Newly Approved Drug Therapies (562): Proventil HFA Inhalation Aerosol, 3M Pharmaceuticals

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Proventil HFA Inhalation Aerosol

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: 3M Pharmaceuticals
Approval Status: Approved June 1999
Treatment for: Pulmonary/Respiratory Diseases

General Information

The approval of Proventil HFA (albuterol sulfate) Inhalation Aerosol covers a supplemental new drug application that provides for the following: lowering the age from 12 years to 4 years and older for the treatment or prevention of

bronchospasm with reversible obstructive airway disease
exercise-induced bronchospasm

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]